index
376
Care of the High-Risk Neonate,
135
Catheters. See Intravenous (IV)
therapy; Umbilical
catheters
Cefotaxime, 296
Ceftriaxone, 257, 296
Central apnea, 63
Central cyanosis, 8
Central nervous system disorders
apnea and, 64
low blood pressure and, 174
Central venous catheters and intrave-
nous therapy, 193
Cephalosporins, 257, 294
Cephalothin, 296
Cesarean section
human immunodeficiency virus
and, 304
low blood pressure and, 168
respiratory distress and, 55
Chest tubes, 72
for pneumothorax detection,
91–93
for pneumothorax treatment, 95,
101–113, 115–120
wire-guided insertion, 115–120
Chest x-rays, 58, 71, 81, 87–93,
358
Chicken pox, 298, 313
Chlamydial infections, 295
Choanal atresia, 53, 57, 361
Clotted catheters, 127
CMV. See Cytomegalovirus (CMV)
Cold stress, 54
apnea and, 63
Collapsed lung. See Pneumothorax
Color, skin, 57, 333
Commercial formulas, 221, 230
Communication with parents, 366
Complete blood count (CBC), 359
Complications of umbilical catheters,
128–129
Congenital heart disease
cyanotic, 10
low blood pressure and, 168, 176
respiratory distress and, 54
transport for, 360
Congenital infections, 285–286,
298–299
Congenital intrauterine infections,
288, 291
Congenital malformations, 361
Conjunctivitis, 296
Continuous infusion, 127
Continuous positive airway pressure
(CPAP), 12
apnea and, 66
misplaced apparatuses, 53
pneumothorax and, 69
respiratory distress and, 59
CPAP. See Continuous positive air-
way pressure (CPAP)
C-reactive protein (CRP), 293
CRP. See C-reactive protein (CRP)
Cyanosis, 8, 9
color and, 333
pneumothorax and, 70
prematurity without, 10
respiratory distress and, 51, 52, 57
Cyanotic congenital heart disease, 10
Cytomegalovirus (CMV), 298
D
Dextrose, 195
Diabetes mellitus, babies of women
with, 55
Diaphragmatic hernia, 53, 57, 361
Diastolic blood pressure, 167
Difficult births and respiratory
distress, 55
Disconnected catheters, 128
Distended abdomen, 70, 219
Dopamine, 176
Dorsalis pedis artery, 37
E
Ehrenkranz curves, 228
Electrolytes, 338
Emboli
oxygenation and, 35
umbilical catheters and, 129
Emotional attachment with babies,
encouraging, 365–366
Erb palsy, 54
Erythromycin, 295
Esophageal atresia, 57
Excess fluid in umbilical catheters,
128
Excessive handling and respiratory
distress, 54
Exchange transfusion, 261, 265–266
Eye damage and oxygen therapy, 14
F
Feeding, 218
dangers of, 219
iron supplementation and, 230
multivitamin supplementation
and, 230
nasogastric tube, 234, 241–249
observation of, 334
posttest, 239
pretest, 216–217
quantities for appropriate-for-
gestational-age babies,
221–223
quantities for small-for-gesta-
tional-age babies, 223–224
recommended routines, 237
satisfactory baby growth and,
225–228
self-tests, 224, 231, 234, 238
sick and at-risk babies, 329
tracking baby’s growth and, 229
tube, 232–235
what type of milk should be used
in, 220–221
which babies are at risk for devel-
oping problems with, 219
Femoral artery, 38
Fetal-maternal transfusion and low
blood pressure, 168
Flaring, nasal, 51, 52
Fluctuations in oxygen concentra-
tion, 11
Fluid loss, 194
Flush volume, 127
Formulas, commercial, 221, 230
Free radicals, 5
G
Gag reflex, 233
Gastroschisis, 361
Generalized fetal edema, 56
Gentamicin, 294
Gestational age, 221–223, 326, 328,
329, 356
Glucose-6-phosphate dehydrogenase
[G6PD] deficiency, 256,
257, 266
Gonococcal infections, 296
G6PD deficiency. See Glucose-6-
phosphate dehydrogenase
[G6PD] deficiency
Gram-negative bacteria, 285
Gram-positive bacteria, 285
Growth
charts, 225–228
tracking, 229
Grunting, 51, 52, 57
H
Hand washing, 312, 330
HBV. See Hepatitis B virus (HBV)
Heart disease. See Congenital heart
disease
Previous Page Next Page